National Institute on Drug Abuse; Notice of Closed Meeting, 55951 [2024-14870]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 130 / Monday, July 8, 2024 / Notices
HRSA specifically requests comments
on: (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions; (2) the accuracy of the
estimated burden; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024–14790 Filed 7–5–24; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Secretary’s Advisory
Committee on Human Research
Protections
Department of Health and
Human Services, Office of the Secretary,
Office of the Assistant Secretary for
Health.
ACTION: Notice.
AGENCY:
Pursuant to the Federal
Advisory Committee Act, notice is
hereby given that the Secretary’s
Advisory Committee on Human
Research Protections (SACHRP) will
hold a meeting that will be open to the
public. Information about SACHRP, the
full meeting agenda, and instructions for
linking to public access will be posted
on the SACHRP website at https://
www.hhs.gov/ohrp/sachrp-committee/
meetings/.
DATES: The meeting will be held on
Tuesday, July 23, 2024 from 11:00 a.m.
until 4:00 p.m., and Wednesday, July
24, 2024, from 11:00 a.m. until 4:00 p.m.
(times are tentative and subject to
change). The confirmed times and
agenda will be posted on the SACHRP
website as this information becomes
available.
ADDRESSES: This meeting will be held
via webcast. Members of the public may
also attend the meeting via webcast.
Instructions for attending via webcast
will be posted at least one week prior
to the meeting at https://www.hhs.gov/
ohrp/sachrp-committee/meetings/
index.html.
FOR FURTHER INFORMATION CONTACT: Julia
Gorey, J.D., Executive Director,
SACHRP; U.S. Department of Health
and Human Services, 1101 Wootton
Parkway, Suite 200, Rockville,
Maryland 20852; telephone: 240–453–
8141; fax: 240–453–6909; email address:
SACHRP@hhs.gov.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:22 Jul 05, 2024
Jkt 262001
Under the
authority of 42 U.S.C. 217a, section 222
of the Public Health Service Act, as
amended, SACHRP was established to
provide expert advice and
recommendations to the Secretary of
Health and Human Services, through
the Assistant Secretary for Health, on
issues and topics pertaining to or
associated with the protection of human
research subjects.
The Subpart A Subcommittee (SAS)
was established by SACHRP in October
2006 and is charged with developing
recommendations for consideration by
SACHRP regarding the application of
subpart A of 45 CFR part 46 in the
current research environment.
The Subcommittee on Harmonization
(SOH) was established by SACHRP at its
July 2009 meeting and charged with
identifying and prioritizing areas in
which regulations and/or guidelines for
human subjects research adopted by
various agencies or offices within HHS
would benefit from harmonization,
consistency, clarity, simplification and/
or coordination.
The SACHRP meeting will open to the
public at 11:00 a.m., on Tuesday, July
23, 2024, followed by opening remarks
from Julie Kaneshiro, Acting Director of
OHRP and Dr. Douglas Diekema,
SACHRP Chair. The meeting will begin
with a discussion of the draft
recommendation, Ethical and
Regulatory Considerations for the
Inclusion of LGBTQI+ Populations in
HHS Human Subjects Research. This
topic is a continuation of the discussion
and speaker panel presented at the
October 2023 SACHRP. This will be
followed by discussion of
Considerations for Uninformative
Research. OHRP will also provide an
update on planned changes to the
structure and operation of SACHRP’s
subcommittees. The first day will
adjourn at approximately 4:00 p.m. The
second day of the meeting, July 24, will
begin at 11:00 with a continued
discussion of the previous day’s topics.
Other topics may be added; for the full
and updated meeting agenda, see https://
www.dhhs.gov/ohrp/sachrp-committee/
meetings/. The meeting will
adjourn by 4:00 p.m., July 24, 2024.
Time will be allotted for public
comment on both days of the meeting.
SACHRP materials will be publicly
posted at https://www.regulations.gov/,
docket # HHS–OASH–2024–0008. The
public may submit written public
comment in advance to SACHRP@
hhs.gov no later than midnight July
19th, 2024, ET. Written comments will
be shared with SACHRP members and
may read aloud during the meeting.
Comments which are read aloud are
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
55951
limited to three minutes each. Public
comment must be relevant to topics
currently being addressed by the
SACHRP.
Dated: July 2, 2024.
Yvonne Lau,
Acting Director, Office for Human Research
Protections.
[FR Doc. 2024–14865 Filed 7–5–24; 8:45 am]
BILLING CODE 4150–36–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIDA–
K Alternate SEP.
Date: August 1, 2024.
Time: 12:00 p.m. to 12:45 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892.
Contact Person: Marisa Srivareerat, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Office of Extramural Policy, National
Institute on Drug Abuse, NIH, 301 North
Stonestreet Avenue, MSC 6021, Bethesda,
MD 20892, (301) 435–1258,
marisa.srivareerat@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: July 2, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–14870 Filed 7–5–24; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\08JYN1.SGM
08JYN1
]]>Agencies
[Federal Register Volume 89, Number 130 (Monday, July 8, 2024)]
[Notices]
[Page 55951]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-14870]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; NIDA-K Alternate SEP.
Date: August 1, 2024.
Time: 12:00 p.m. to 12:45 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892.
Contact Person: Marisa Srivareerat, Ph.D., Scientific Review
Officer, Scientific Review Branch, Office of Extramural Policy,
National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue,
MSC 6021, Bethesda, MD 20892, (301) 435-1258,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse and Addiction Research Programs, National
Institutes of Health, HHS)
Dated: July 2, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-14870 Filed 7-5-24; 8:45 am]
BILLING CODE 4140-01-P
